SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020.
Age Factors
COVID-19
/ diagnosis
COVID-19 Serological Testing
/ methods
Cross-Sectional Studies
Demography
Female
Humans
Male
Military Health
/ ethnology
Military Health Services
Military Personnel
/ statistics & numerical data
Personnel Selection
/ methods
Quarantine
SARS-CoV-2
/ immunology
Seroepidemiologic Studies
United States
/ epidemiology
Young Adult
COVID-19
SARS-CoV-2
United States
coronavirus disease
military recruits
respiratory infections
seroprevalence
severe acute respiratory syndrome coronavirus 2
viruses
young adults
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
pubmed:
3
2
2021
medline:
2
4
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
In a study of US Marine recruits, seroprevalence of severe acute respiratory syndrome coronavirus 2 IgG was 9.0%. Hispanic and non-Hispanic Black participants and participants from states affected earlier in the pandemic had higher seropositivity rates. These results suggest the need for targeted public health strategies among young adults at increased risk for infection.
Identifiants
pubmed: 33529569
doi: 10.3201/eid2704.204732
pmc: PMC8007328
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1188-1192Références
JAMA Intern Med. 2020 Sep 9;:
pubmed: 32902580
Soc Sci Med. 2021 Jan;268:113370
pubmed: 32980677
JAMA Intern Med. 2021 Apr 1;181(4):450-460
pubmed: 33231628
Lancet. 2020 Sep 25;:
pubmed: 32987007
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Rev Saude Publica. 2020;54:69
pubmed: 32638883
JAMA. 2020 Jul 28;324(4):392-395
pubmed: 32556212
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):714-721
pubmed: 32525850
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
N Engl J Med. 2020 Dec 17;383(25):2407-2416
pubmed: 33176093
J Infect. 2020 Jun;80(6):e1-e13
pubmed: 32283156
Am J Public Health. 2020 Oct;110(10):1506-1508
pubmed: 32903081